Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
50 articles
Dyadic (DYAI) 2025 Earnings: Key Takeaways for Investors
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Why Lenz Therapeutics Stock Crashed Today: 2026 Lessons
Biotech stocks can swing on earnings surprises. This article explains why lenz therapeutics stock crashed, what it me...
Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
This $8.9 Million Targets a Stock Down 68% with Cash
A disciplined investor asks: can a modest, cash-backed bet on a distressed stock generate alpha? This article breaks ...
Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
What Make Adviser's Ocular Signals for VR Adviser Trades
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Related Topics
#Stock Analysis (10)
#Portfolio Management (10)
#Earnings Analysis (8)
#Investing (6)
#Stock Market (5)
#Investment Strategy (4)
#Portfolio Strategy (4)
#risk-management (4)
#Earnings (3)
#Healthcare Stocks (3)
#portfolio-allocation (3)
#Stock Market News (3)
#Stock Picks (2)
#Q4 2025 (2)
#Hedge Funds (2)